Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-7585.86%
operating margin TTM
-7877.46%
revenue TTM
N/A
revenue per share TTM
0.0$
valuation ratios | |
|---|---|
| pe ratio | -14.00 |
| peg ratio | -21.64 |
| price to book ratio | 11.03 |
| price to sales ratio | 1,148.48 |
| enterprise value multiple | -16.61 |
| price fair value | 11.03 |
profitability ratios | |
|---|---|
| gross profit margin | 97.1% |
| operating profit margin | -7877.46% |
| pretax profit margin | -7595.7% |
| net profit margin | -7585.86% |
| return on assets | -63.13% |
| return on equity | -69.59% |
| return on capital employed | -76.0% |
liquidity ratios | |
|---|---|
| current ratio | 7.27 |
| quick ratio | 7.27 |
| cash ratio | 6.81 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 35.86 |
| days of payables outstanding | 17,962.96 |
| cash conversion cycle | -17,927.10 |
| receivables turnover | 10.18 |
| payables turnover | 0.02 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.00 |
| debt equity ratio | 0.00 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.00 |
| interest coverage | 0.00 |
| cash flow to debt ratio | 0.00 |
cash flow ratios | |
|---|---|
| free cash flow per share | -2.02 |
| cash per share | 3.88 |
| operating cash flow per share | -2.02 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | 0.00 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -51,788.00 |
Frequently Asked Questions
When was the last time Immunovant, Inc. (NASDAQ:IMVT) reported earnings?
Immunovant, Inc. (IMVT) published its most recent earnings results on 20-05-2026.
What is Immunovant, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Immunovant, Inc. (NASDAQ:IMVT)'s trailing twelve months ROE is -69.59%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Immunovant, Inc. (IMVT) currently has a ROA of -63.13%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did IMVT's net profit margin stand at?
IMVT reported a profit margin of -7585.86% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is IMVT's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 7.27 in the most recent quarter. The quick ratio stood at 7.27, with a Debt/Eq ratio of 0.00.